Award NoticeActiveSPE2D221R0113
Rivastigmine 24HR Patches
DEPT OF DEFENSE / DEFENSE LOGISTICS AGENCY / DLA TROOP SUPPORTKey dates?
- Posted?
- Sep 14, 2022
- Response deadline?
- —
- Archive date?
- Sep 14, 2028
- Archive type?
- autocustom
Classification?
- Notice type?
- Award Notice
- Base type?
- Solicitation
- Set-aside?
- —
- Set-aside code?
- —
- PSC?
- 6505
NAICS?
- 325412Pharmaceutical Preparation Manufacturing
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--
Issuing office?
- Department?
- DEPT OF DEFENSE
- Sub-tier?
- DEFENSE LOGISTICS AGENCY
- Office?
- DLA TROOP SUPPORT
- Office code?
- —
- Organization type?
- OFFICE
- Office address?
- PHILADELPHIA, PA, 19111, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- Saint Albans
- State?
- VT
- Zip?
- 05478
- Country?
- USA
Contacts?
- Phyllis Daraioprimary
Description?
Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.
Award?
- Number?
- SPE2D222D0147
- Amount?
- $10,967,220.00
- Date?
- Sep 14, 2022
- Awardee?
- Mylan Pharmaceuticals Inc. WV 26505-2362 USA
- UEI?
- —
- Awardee address?
- —
Other notices in this solicitation?
- Award NoticeRivastigmine 24HR PatchesAug 14, 2024LATEST
- Award NoticeRivastigmine 24HR PatchesAug 22, 2023
- Award NoticeRivastigmine 24HR PatchesAug 22, 2023
- SolicitationRivastigmine 24HR PatchesFeb 25, 2022
- SolicitationRivastigmine 24HR PatchesFeb 9, 2022
- SolicitationRivastigmine 24HR PatchesJan 14, 2022
- PresolicitationRivastigmine 24HR PatchesSep 30, 2021
Similar open contracts
Similar past awards
Metadata?
- Notice ID?
- 64f180effe4247a4a61bd716078dadc9
- Full path?
- DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
- Office code?
- —
- Ingested?
- May 2, 2026
- Updated?
- May 2, 2026
Raw record
{
"CGAC": "097",
"City": "PHILADELPHIA",
"Link": "https://sam.gov/workspace/contract/opp/64f180effe4247a4a61bd716078dadc9/view",
"Sol#": "SPE2D221R0113",
"Type": "Award Notice",
"State": "PA",
"Title": "Rivastigmine 24HR Patches",
"Active": "Yes",
"Award$": "10967220.00",
"Office": "DLA TROOP SUPPORT",
"PopZip": "05478",
"Awardee": "Mylan Pharmaceuticals Inc. WV 26505-2362 USA",
"PopCity": "Saint Albans",
"ZipCode": "19111",
"AAC Code": "SPE2D2",
"BaseType": "Solicitation",
"NoticeId": "64f180effe4247a4a61bd716078dadc9",
"PopState": "VT",
"SetASide": "",
"Sub-Tier": "DEFENSE LOGISTICS AGENCY",
"AwardDate": "2022-09-14",
"FPDS Code": "97AS",
"NaicsCode": "325412",
"PopCountry": "USA",
"PostedDate": "2022-09-14 11:21:01.833-04",
"ArchiveDate": "2028-09-14",
"ArchiveType": "autocustom",
"AwardNumber": "SPE2D222D0147",
"CountryCode": "USA",
"Description": "Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.",
"SetASideCode": "",
"OrganizationType": "OFFICE",
"PopStreetAddress": "",
"ResponseDeadLine": "",
"PrimaryContactFax": "",
"AdditionalInfoLink": "",
"ClassificationCode": "6505",
"PrimaryContactEmail": "Phyllis.Daraio@dla.mil",
"PrimaryContactPhone": "2157377941",
"PrimaryContactTitle": "",
"SecondaryContactFax": "",
"Department/Ind.Agency": "DEPT OF DEFENSE",
"SecondaryContactEmail": "",
"SecondaryContactPhone": "",
"SecondaryContactTitle": "",
"PrimaryContactFullname": "Phyllis Daraio",
"SecondaryContactFullname": ""
}